AzTrials
AzTrials

Spinal Cord InjuriesNCT05472584

Spinal Cord Stimulation and Training

A study testing Electrophysiology assessment - corticospinal tract, Electrophysiology assessment - reticulospinal tract and Electrophysiology assessment - spinal motoneuron in people with Spinal Cord Injuries, run by Washington University School of Medicine at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This study will help the investigators better understand the changes in short-term excitability and long-term plasticity of corticospinal, reticulospinal and spinal neural circuits and how the changes impact the improvements of spinal cord stimulation (SCS) mediated motor function. Read more about this study

Who is it for?
Ages 16 to 65 yearsHealthy volunteers can take part
Conditions the study is for
Spinal Cord Injuries
What is being tested?
Electrophysiology assessment - corticospinal tract, Electrophysiology assessment - reticulospinal tract and Electrophysiology assessment - spinal motoneuron
Could I receive a placebo?
No, everyone receives an active treatment
How many people
120 participants
Where
1 siteUnited States
Study dates
21 Jul 2023to Aug 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 16 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Who may be able to join

  • Healthy Volunteers
  • Age between 16 and 65 years old
  • Healthy people with no major comorbidities of any organ system
  • Participants with spinal cord injury (SCI)
  • Age between 16-65 years old
  • Traumatic SCI C4-T9 level, incomplete (ASIA C or D)
Show all 11Show fewer
  • at least 1 year post injury
  • Stable medical condition
  • difficulty independently performing leg movements in routine activities
  • able to follow simple commands
  • able to speak and respond to questions

Who cannot join

  • Healthy Volunteers
  • Subjects younger than 16 or older than 65 years old
  • Subjects not providing consent or not able to consent
  • Subjects with any acute or chronic pain condition
  • Subjects with any acute or chronic disease of a major organ system
  • Use of analgesics within 24 hours prior to study period
Show all 33Show fewer
  • Use of caffeine with 3 hours of study appointment
  • Participants with spinal cord injury (SCI)
  • Subjects younger than 16 or older than 65 years old
  • Not willing or able to provide consent
  • Any acute or chronic pain condition
  • Any acute or chronic disease of a major organ system
  • Use of analgesics within 24 hours prior to study appointment
  • Use of caffeine with 3 hours of study appointment
  • Presence of tremors, spasms and other significant involuntary movements
  • Etiology of SCI other than trauma
  • Concomitant neurologic disease traumatic brain injury (TBI) that will significantly impact the ability to follow through on study directions, multiple sclerosis (MS), stroke or peripheral neuropathy)
  • History of significant medical illness (cardiovascular disease, uncontrolled diabetes, uncontrolled hypertension, osteoporosis, cancer, chronic obstructive pulmonary disease, severe asthma requiring hospitalization for treatment, renal insufficiency requiring dialysis, autonomic dysreflexia, etc).
  • Severe joint contractures disabling or restricting lower limb movements.
  • Unhealed fracture, contracture, pressure sore, urinary tract infection or other uncontrolled infections, other illnesses that might interfere with lower extremity exercises or testing activities
  • Depression, anxiety, or cognitive impairment
  • Deficit of visuospatial orientation
  • Sitting tolerance less than 1 hour
  • Severe hearing or visual deficiency
  • Miss more than 3 appointments without notification
  • Unable to comply with any of the procedures in the protocol
  • Botulinum toxin injection in lower extremity muscles in the prior six months
  • Any passive implants (osteosynthesis material, metallic plates or screws) below T9.
  • Any implanted stimulator in the body (pacemaker, vagus nerve stimulator, etc.)
  • History of alcoholism or another drug abuse
  • Pregnancy (or possible pregnancy)
  • Having an Intrathecal Baclofen Therapy Pump (ITB pump)
  • History of epilepsy

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Ismael Seanez, PHD contact

314-935-7665

ismaelseanez@wustl.edu

United States1 site, 1 recruiting
  • Washington University

    St Louis, Missouri, 63130

    Ismael Seanez, PHD, 314-935-7665, ismaelseanez@wustl.edu

    Recruiting

Other trials in United States

About this study

Official title: Neural Plasticity by Spinal Cord Stimulation and Training in People With Spinal Cord Injury

This study will help the investigators better understand the changes in short-term excitability and long-term plasticity of corticospinal, reticulospinal and spinal neural circuits and how the changes impact the improvements of spinal cord stimulation (SCS) mediated motor function.

Read the detailed description

The goal of this project is to determine the changes in short-term excitability and long-term plasticity of corticospinal, reticulospinal, and spinal neural circuits that are involved in SCS-mediated motor function improvements in individuals with spinal cord injury (SCI). The study will: (1) Determine the short-term effects in neural excitability induced by SCS and activity-based training. (2) Determine the effect of motor training on short-term changes in neural excitability enabled by SCS. (3) Determine the long-term changes in motor control and neural plasticity induced by combined SCS and activity-based training in individuals with chronic SCI. Having a better understanding of the neural mechanisms that are enhanced by SCS can allow the development of therapies that directly target the excitability and plasticity states of these structures towards improved and accelerated recovery.

Being tested
Electrophysiology assessment - corticospinal tract, Electrophysiology assessment - reticulospinal tract, Electrophysiology assessment - spinal motoneuron, Activity-based training, Transcutaneous spinal cord stimulation
Keywords
spinal cord injury, spinal cord stimulation, rehabilitation
Medical subject headings
Spinal Cord Injuries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Electrophysiology assessment - corticospinal tractOther

    Kinematics and cortical spinal motor excitability

  • Electrophysiology assessment - reticulospinal tractOther

    Kinematics and reticular spinal motor excitability

  • Electrophysiology assessment - spinal motoneuronOther

    Kinematics and spinal motoneuron excitability

  • Activity-based trainingOther

    Motor task

  • Transcutaneous spinal cord stimulationOther

    Non-invasive spinal cord stimulation

Study groups in NCT05472584
Study groupRoleWhat they receive
Experimental: Non-invasive spinal cord stimulationExperimentalThis arm will receive 30 minutes of transcutaneous spinal cord stimulation as participants rest.
Receives: Other: Electrophysiology assessment - corticospinal tract; Other: Electrophysiology assessment - reticulospinal tract; Other: Electrophysiology assessment - spinal motoneuron; Other: Transcutaneous spinal cord stimulation
Experimental: Activity-based trainingExperimentalThis arm will perform 30 minutes of activity-based training using leg movements.
Receives: Other: Electrophysiology assessment - corticospinal tract; Other: Electrophysiology assessment - reticulospinal tract; Other: Electrophysiology assessment - spinal motoneuron; Other: Activity-based training
Experimental: Activity-based training wtih non-invasive spinal cord stimulationExperimentalThis arm will receive transcutaneous spinal cord stimulation as participants perform 30 minutes of activity-based training using leg movements.
Receives: Other: Electrophysiology assessment - corticospinal tract; Other: Electrophysiology assessment - reticulospinal tract; Other: Electrophysiology assessment - spinal motoneuron; Other: Activity-based training; Other: Transcutaneous spinal cord stimulation
Experimental: Non-invasive spinal cord stimulation and strength trainingExperimentalThis arm will receive transcutaneous spinal cord stimulation as participants perform strengthening exercises.
Receives: Other: Electrophysiology assessment - corticospinal tract; Other: Electrophysiology assessment - reticulospinal tract; Other: Electrophysiology assessment - spinal motoneuron; Other: Activity-based training; Other: Transcutaneous spinal cord stimulation
Experimental: Non-invasive spinal cord stimulation and precision trainingExperimentalThis arm will receive transcutaneous spinal cord stimulation as participants perform precision-control and dexterity exercises.
Receives: Other: Electrophysiology assessment - corticospinal tract; Other: Electrophysiology assessment - reticulospinal tract; Other: Electrophysiology assessment - spinal motoneuron; Other: Activity-based training; Other: Transcutaneous spinal cord stimulation
Experimental: Long-term activity-based training with non-invasive spinal cord stimulationExperimentalThis arm will receive 4 weeks of activity-based training with transcutaneous spinal cord stimulation
Receives: Other: Electrophysiology assessment - corticospinal tract; Other: Electrophysiology assessment - reticulospinal tract; Other: Electrophysiology assessment - spinal motoneuron; Other: Activity-based training; Other: Transcutaneous spinal cord stimulation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Motor evoked potentials amplitude and latency

    This primary outcome is a measure of changes in corticospinal tract excitability and plasticity as quantified by changes in the amplitude size and onset latency of motor evoked potentials elicited via transcranial magnetic stimulation.

    Measured: 30 minutes before and 30 minutes after intervention; 4 weeks

  2. Reaction time to startle response

    This primary outcome is a measure of changes in reticulospinal tract excitability after training as quantified by changes in reaction time after a startling auditory stimulus.

    Measured: 30 minutes before and 30 minutes after intervention; 4 weeks

  3. F-wave response persistence

    This primary outcome is a measure of changes in spinal motoneuron excitability as quantified by changes in the persistence of F-wave responses elicited via peripheral nerve stimulation.

    Measured: 30 minutes before and 30 minutes after intervention; 4 weeks

Secondary outcomes (2)
  1. Changes in time to completion from baseline

    Participants will perform cursor control as a computer game. This outcome measure is the time it takes participants to complete each task.

    Measured: Baseline, 30 minutes, and 4 weeks

  2. Change in movement smoothness

    This outcome is a measure of changes in movement smoothness when operating the computer cursor with the body.

    Measured: Baseline, 30 minutes, and 4 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Jul 2022
  2. Study start21 Jul 2023
  3. Primary completionAug 2027 (estimated)
  4. Study completionAug 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Crossover
Masking
None (open label)
Enrolment
120 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05472584
Sponsor's protocol ID
202206159
Status last verified
Mar 2026
First submitted
8 Jul 2022
Last updated
2 Apr 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Electrophysiology assessment - corticospinal tract, Electrophysiology assessment - reticulospinal tract and Electrophysiology assessment - spinal motoneuron in people with Spinal Cord Injuries, run by Washington University School of Medicine at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 11 inclusion and 33 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 2 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Ismael Seanez, PHD (314-935-7665, ismaelseanez@wustl.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Motor evoked potentials amplitude and latency (time frame: 30 minutes before and 30 minutes after intervention; 4 weeks). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Apr 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in